NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cansativa Group

Cansativa Group

Private
Mörfelden-WalldorfHealthcare & Life Scienceshttps://www.cansativa.de/

Last Round

Series B

Feb 16, 2022

Est. Valuation

$17.6M

Total Funding Raised

$23M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Cansativa Group is a pharmaceutical company that provides market access, warehousing, and distribution for medical cannabis products.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, E-commerce, Logistics Software

Business Model

B2B

Customer Profile

Marketplace Commission, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

medical cannabis distributionB2B cannabis platformcannabis marketplaceGerman cannabis marketpharmaceutical wholesalecanna techmedical marijuanacannabis importercannabis supply chaincannabis logisticspharmacy procurementGMP certificationGDP certificationcannabis flowerscannabis extracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cansativa Group Comparables

Compare Cansativa Group with similar companies based on industry and business-model similarity.

Cansativa Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
enua Pharma GmbH
88%
Semdor Pharma Group
85%
alephSana GmbH
85%

Cansativa Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 16, 2022
Series AJun 22, 2021
SeedFeb 20, 2019

Key People

Founding team and executive leadership

Benedikt Sons

Co-Founder, Managing Director CEO

Founding Team

Mario Scheliga

Chief Technology Officer

Executive Team

Roland Schneller

Managing Director And COO

Executive Team

Cansativa Group Investors

Notable investors and investment history

Cansativa Group investors
InvestorRounds
Greenfield OneSeries A
Argonautic VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 6, 2026

    Open roles increased from 0 to 19, representing 33% of headcount.

Cansativa Group Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cansativa Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cansativa Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersMörfelden-Walldorf
Employee Range58
Year Founded2017
Last FundingFeb 16, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.